One global company innovating for millions. Covance is now Labcorp Drug Development.

Moving ahead, Covance will be known as Labcorp Drug Development—reflecting years of shared pursuit with Labcorp delivering health breakthroughs. With unmatched global

scale, scientific expertise and virtual clinical trial capabilities, we are determined to keep pushing forward to help bring cutting-edge treatments to patients everywhere.

Go to article: Home | Drug dealing goes digital Go to article: In this issueGo to article: ContentsGo to article: SyrenisGo to article: Astrix Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Thermo Fisher Scientific Company InsightGo to article: Thermo Fisher ScientificGo to article: CommentGo to article: Life sciences professionals prioritise quality over cost for PV automationGo to article: Slow progress for male contraceptive trialsGo to article: Accelerated approval designations in ChinaGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: The dark consequences of supply shortagesGo to article: Digitising the pharma supply chainGo to article: Covid-19 vaccine pricing varies wildly by country and company Go to article: Psychedelics and mental health: the next big thing?Go to article: Schizophrenia drug landscape: a stagnant field on the cusp of change?Go to article: Are supercomputers set to transform pharma R&D?Go to article: BEA TechnologiesGo to article: LabcorpGo to article: In DataGo to article: North America's AI hiring boomGo to article: The pharma companies leading the way in artificial intelligenceGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue